Biotech Avoids Tech Wreck of June 9…Update-2 June 15
June 15-Update 2 after close...Biotechs Down with Techs-Red Screen Day Very few winners today: IBB down 0.77%, XBI down 1.36% to $71.55 near 52 week high of $73. ABBV near new highs at $70.60, BLUE up 24.7% for past month. EPZM soars 17% on EZH2 inhibitor, RXDX up 5.8% continues run on NTRK...
ASCO Update #2: Stock Performance Data as of 6/8/17
ASCO Update: Many Stocks Rallied on the News Over the Past Month ASCO Rally is Holding but Fails to Break Through to New 2017 Highs The stock performance of most companies with ASCO news is summarized below.Biotechnology stocks are driven by clinical and deal news so here are some trends to...
ASCO Update: Movers on the News-INCY PBYI RHHBY
June 5...ASCO Update: Incyte Puma and Roche A lot of the product news is already "baked into" stock prices but here is a brief summary of big movers today on clinical news updates. The bellwether XBI peaked at $71.72 today and is down 0.62% to $70.66. bluebird bio (BLUE) up 8.5% to $91.30 BLUE...
Biotechs Sink Again in Sector Shift to Technology Stocks: Update-1
6/1/17 Update at close...Biotechs Bounce off Bottom of 3 Month Trading Range IBB up 1.8% back above $290 after hitting 200 SMA bottom. XBI up 2.7% to $69.54 at SMA 50. XBI 2017 top is $72. XLV a safer play up over 1% to $76.91; above March highs and near 12 mo. highs up 11.58% YTD. Broad rally...
Biotech Fades After ASCO Abstract Rally
Biotech Fades with Profit Taking: Is the pre-ASCO Momentum Gone? Technicals Matter Drug Pricing Scrutiny Continues Biotechs faded today now that the rush of oncology drug news slowed down. NASDAQ retained momentum with the ETF leader QQQ up 19% YTD pulling ahead of the biotech ETFs. Large cap...